SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-002247
Filing Date
2024-01-08
Accepted
2024-01-08 16:15:50
Documents
17
Period of Report
2024-01-04
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm242158d2_8k.htm   iXBRL 8-K 34532
2 EXHIBIT 10.1 tm242158d2_ex10-1.htm EX-10.1 40215
3 EXHIBIT 10.2 tm242158d2_ex10-2.htm EX-10.2 234554
4 EXHIBIT 10.3 tm242158d2_ex10-3.htm EX-10.3 198598
5 EXHIBIT 99.1 tm242158d2_ex99-1.htm EX-99.1 19278
6 EXHIBIT 99.2 tm242158d2_ex99-2.htm EX-99.2 26423
  Complete submission text file 0001104659-24-002247.txt   850414

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA lqda-20240104.xsd EX-101.SCH 3015
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE lqda-20240104_lab.xml EX-101.LAB 34240
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lqda-20240104_pre.xml EX-101.PRE 22359
11 EXTRACTED XBRL INSTANCE DOCUMENT tm242158d2_8k_htm.xml XML 3284
Mailing Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560
Business Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560 919.328.4400
Liquidia Corp (Filer) CIK: 0001819576 (see all company filings)

IRS No.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39724 | Film No.: 24520316
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)